Sudden cardiac death: opportunities for prevention
- PMID: 16159972
- PMCID: PMC1860649
- DOI: 10.1136/hrt.2005.073726
Sudden cardiac death: opportunities for prevention
Abstract
The evidence base for implantable cardioverter-defibrillator (ICD) therapy requires expansion of guidance/indications to allow UK physicians to treat a broader range of patients. The ICD clinical consultees to the National Institute for Health and Clinical Excellence (NICE) review current guidance/guidelines, explain the evidence base, and suggest a UK ICD implantation strategy.
Conflict of interest statement
Potential conflicts of interests: JMM, JCC, and JMMcC advised the NICE appraisal committee on behalf of the British Cardiac Society, the Royal College of Physicians and Heart Rhythm UK (formerly the British Pacing and Electrophysiology Group). The reviews expressed in this paper are, however, their own and not necessarily those of the bodies they represented.
References
-
- Department of Health Chapter 8. Arrhythmias and sudden cardiac death. In,National service framework for coronary heart disease. London, Department of Health 2005
-
- National Institute for Clinical Excellence Technology Appraisal Guidance No 11 Guidance on the use of implantable cardioverter defibrillators for arrhythmias. London: NICE, September, 2000
-
- National Institute for Health and Clinical Excellence Appraisal Consultation Document: implantable cardioverter defibrillators for arrhythmias (review of existing guidance no. 11). London: NICE, 2005
-
- Cunningham A, Cunningham M, Rickards A F. National pacemaker database. National ICD database 2002
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical